Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01060774 · ClinicalTrials.gov registry record · Phase 4
Bupivacaine Versus Lidocaine on Inflammatory Regulation
A Phase 4 study of Pain, sponsored by University of Maryland.
- Completed
- Registry status
- Phase 4
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT01060774: Completed Phase 4 study of Pain, sponsored by University of Maryland.
NCT01060774 is a Phase 4 study of Pain that has completed, run by University of Maryland. The registered enrollment target is 11 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01060774, a Phase 4 study of Pain, has completed, sponsored by University of Maryland.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is testing a local anesthetic (numbing medicine) to suppress pain. Bupivacaine and lidocaine are FDA approved local anesthetics that may decrease pain following surgery. Patients will receive either 2% lidocaine, 0.5% bupivacaine, or placebo with epinephrine 1:200,000 as a numbing medicine at the end of root canal surgery. Small pieces of gum will be taken before and after surgery and 2 days later to analyze chemicals that may be related to pain sensation.
Primary Outcome
The difference in inflammatory gene expression between treatment groups.
Conditions Studied
Interventions
- DRUG Bupivacaine
- DRUG Lidocaine
Study Locations (1)
Maryland
- University of Maryland, Baltimore College of Dental Surgery - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2008-07 |
| Est. Completion | 2010-07 |
| Phase | Phase 4 |
What the finished NCT01060774 record still lists
NCT01060774 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Bupivacaine is the first listed.
NCT01060774 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT01060774 about?
NCT01060774 is a clinical study titled "Bupivacaine Versus Lidocaine on Inflammatory Regulation". This study is testing a local anesthetic (numbing medicine) to suppress pain. Bupivacaine and lidocaine are FDA approved local anesthetics that may decrease pain following surgery. Patients will receive either 2% lidocaine, 0.5% bupivacaine, or placebo with epinephrine 1:200,000 as a numbing medicin...
What is the current status of trial NCT01060774?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 11 participants. The study started on 2008-07. Estimated completion is 2010-07.
What conditions does trial NCT01060774 study?
This clinical trial studies the following conditions: Pain.
What interventions are being tested in trial NCT01060774?
The interventions under investigation include: Bupivacaine (DRUG), Lidocaine (DRUG).
Who is sponsoring clinical trial NCT01060774?
This trial is sponsored by University of Maryland, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01060774 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01060774's enrollment target sits among peer trials
11 362nd of 374 higher than 10 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Magnesium on Neuromonitoring
RECRUITING · Phase 4
-
Low-Dose Ketamine Infusion During Burn Wound Care
RECRUITING · Phase 4
-
Optimizing Perioperative Analgesia to Lower Pain Following Cleft Palate Surgery
RECRUITING · Phase 4
-
Optimizing Pain Control in Transurethral Resection of the Prostate
RECRUITING · Phase 4
-
Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia
RECRUITING · Phase 4
-
Regional Blocks for Lateral Condyle Fractures
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia